Загрузка...
Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report
BACKGROUND: Pulmonary hypertension (PH) is one of the significant complications of sarcoidosis. In the clinical classification of PH proposed in the recent world symposium of PH 2018, sarcoidosis-associated PH is classified in Group 5. The mechanisms of sarcoidosis-associated PH are very heterogeneo...
Сохранить в:
| Опубликовано в: : | Eur Heart J Case Rep |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850610/ https://ncbi.nlm.nih.gov/pubmed/33554014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcr/ytaa454 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|